Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?
To say that biotech stocks have performed well as a group over the last two years is an understatement; they have absolutely crushed the broader markets. For example, the iShares Nasdaq Biotech Index has more than tripled the performance of the S&P 500 , and more than doubled the NASDAQ Composite , since 2012.This sustained move upward, though, has repeatedly […]